Prediction of the Overall Renal Tubular Secretion and Hepatic Clearance of Anionic Drugs and a Renal Drug-Drug Interaction Involving Organic Anion Transporter 3 in Humans by In Vitro Uptake Experiments
Authors:
- Takao WatanabeTWTakao Watanabe
- Hiroyuki KusuharaHKHiroyuki Kusuhara
- Tomoko WatanabeTWTomoko Watanabe
- Yasuyuki DeboriYDYasuyuki Debori
- Kazuya MaedaKMKazuya Maeda
- Tsunenori KondoTKTsunenori Kondo
- Hideki NakayamaHNHideki Nakayama
- Shigeru HoritaSHShigeru Horita
- Brian W. OgilvieBOBrian W. Ogilvie
- Andrew ParkinsonAPAndrew Parkinson
- Zhuohan HuZHZhuohan Hu
- Yuichi SugiyamaYSYuichi Sugiyama
- 1 June 2011
- journal article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 39 (6) , 1031-1038
Abstract
The present study investigated prediction of the overall renal tubular secretion and hepatic clearances of anionic drugs based on in vitro transport studies. The saturable uptake of eight drugs, most of which were OAT3 substrates (rosuvastatin, pravastatin, pitavastatin, valsartan, olmesartan, trichlormethiazide, p-aminohippurate, and benzylpenicillin) by freshly prepared human kidney slices underestimated the overall intrinsic clearance of the tubular secretion; therefore, a scaling factor of 10 was required for in vitro-in vivo extrapolation. We examined the effect of gemfibrozil and its metabolites, gemfibrozil glucuronide and the carboxylic metabolite, gemfibrozil M3, on pravastatin uptake by human kidney slices. The inhibition study using human kidney slices suggests that OAT3 plays a predominant role in the renal uptake of pravastatin. Comparison of unbound concentrations and Ki values (1.5, 9.1, and 4.0 μM, for gemfibrozil, gemfibrozil glucuronide, and gemfibrozil M3, respectively) suggests that the mechanism of the interaction is due mainly to inhibition by gemfibrozil and gemfibrozil glucuronide. Furthermore, extrapolation of saturable uptake by cryopreserved human hepatocytes predicts clearance comparable with the observed hepatic clearance although fluvastatin and rosuvastatin required a scaling factor of 11 and 6.9, respectively. This study suggests that in vitro uptake assays using human kidney slices and hepatocytes provide a good prediction of the overall tubular secretion and hepatic clearances of anionic drugs and renal drug-drug interactions. It is also recommended that in vitro-in vivo extrapolation be performed in animals to obtain more reliable prediction.Keywords
This publication has 38 references indexed in Scilit:
- Prediction of Hepatic Clearance in Human From In Vitro Data for Successful Drug DevelopmentThe AAPS Journal, 2009
- Prediction of Drug Clearance by Glucuronidation from in Vitro Data: Use of Combined Cytochrome P450 and UDP-Glucuronosyltransferase Cofactors in Alamethicin-Activated Human Liver MicrosomesDrug Metabolism and Disposition, 2009
- Multiple Human Isoforms of Drug Transporters Contribute to the Hepatic and Renal Transport of Olmesartan, a Selective Antagonist of the Angiotensin II AT1-ReceptorDrug Metabolism and Disposition, 2007
- Species Difference in the Inhibitory Effect of Nonsteroidal Anti-Inflammatory Drugs on the Uptake of Methotrexate by Human Kidney SlicesThe Journal of Pharmacology and Experimental Therapeutics, 2007
- Inhibition of human organic anion transporter 3 mediated pravastatin transport by gemfibrozil and the metabolites in humansXenobiotica, 2007
- A Species Difference in the Transport Activities of H2 Receptor Antagonists by Rat and Human Renal Organic Anion and Cation TransportersThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Interactions of Human Organic Anion Transporters with DiureticsThe Journal of Pharmacology and Experimental Therapeutics, 2004
- A dispersion model of hepatic elimination: 1. Formulation of the model and bolus considerationsJournal of Pharmacokinetics and Biopharmaceutics, 1986
- Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1982
- A pharmacokinetic analysis program (multi) for microcomputer.Journal of Pharmacobio-Dynamics, 1981